Characterization of Heterotopic and Orthotopic Syngeneic MOC1 and MOC2 Tumor Models

被引：0
|
作者：
Rickard, A. [1 ]
Castillo, R. [2 ]
Pittman, A. [3 ]
Gonzales, K. [3 ]
Blocker, S. [3 ]
Shen, X. [3 ]
Clum, P. [1 ]
Everitt, J. [3 ]
Watts, T. [3 ]
Mowery, Y. M. [4 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA
[3] Duke Univ, Durham, NC USA
[4] UPMC, Hillman Canc Ctr, Pittsburgh, PA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
217
引用
收藏
页码：E68 / E68
页数：1
相关论文
共 50 条
  • [41] Characterization of GBM Immunophenotype in Murine Heterotopic and Orthotopic Models, Implications for Novel Treatment Modalities
    Quinn, T. J.
    Kesarwani, P.
    Kant, S.
    Prabhu, A.
    Chinnaiyan, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E647 - E647
  • [42] Orthotopic and heterotopic triple negative breast cancer preclinical murine models: A tumor microenvironment comparative
    Santana-Krimskaya, Silvia Elena
    Kawas, Jorge R.
    Zarate-Trivino, Diana Ginette
    Ramos-Zayas, Yareellys
    Rodriguez-Padilla, Cristina
    Franco-Molina, Moises Armides
    RESEARCH IN VETERINARY SCIENCE, 2022, 152 : 364 - 371
  • [43] Phosphorylations of Sds23/Psp1/Moc1 by stress-activated kinase and cAMP-dependent kinase are essential for regulating cell viability in prolonged stationary phase
    Jang, Young-Joo
    Won, Misun
    Yoo, Hyang-Sook
    YEAST, 2013, 30 (10) : 379 - 394
  • [44] Advantages in using orthotopic syngeneic tumor models to evaluate immune-based approaches for cancer treatment
    Maubant, Sylvie
    Slos, Philippe
    de Boisferon, Marc Hillairet
    Bichat, Francis
    Mirjolet, Jean-Francois
    CANCER RESEARCH, 2018, 78 (13)
  • [45] CO2 hydrogenation to methanol on efficient Pd modified α-MoC1_ x catalysts
    Cao, Mingyang
    Chen, Yuanlin
    Liu, Bing
    Zhang, Zehui
    FUEL, 2024, 375
  • [46] Preparation of α-MoC1-x and β-Mo2C supported on HZSM-5
    Yuan, SD
    Ying, PL
    Li, C
    CHINESE JOURNAL OF CATALYSIS, 2001, 22 (06) : 511 - 512
  • [47] Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model
    Watanabe, Fabio T.
    Chade, Daher C.
    Reis, Sabrina T.
    Piantino, Camila
    Dall' Oglio, Marcos Francisco
    Srougi, Miguel
    Leite, Katia R. M.
    CLINICS, 2011, 66 (12) : 2121 - 2124
  • [48] Molecular characterization of mouse syngeneic tumor models in response to treatment with anti-PD-1 immunotherapy
    Hirsch, Heather A.
    Pinheiro, Elaine M.
    Cai, Mingmei
    Ma, Yanhong
    Sathe, Manjiri
    Ayers, Mark
    McClanahan, Terrill K.
    CANCER RESEARCH, 2015, 75
  • [49] Preparation of α-MoC1-x and β-Mo2C Supported on HZSM-5
    YUAN Shandong
    催化学报, 2001, (06) : 511 - 512
  • [50] Establishment and characterization of pediatric brain tumor models in an orthotopic mouse model
    Oswald, Eva
    Lashuk, Kanstantsin
    Gojo, Johannes
    Lenhard, Dorothee
    Mack, Norman
    Krausert, Sonja
    Loetsch, Daniela
    Jones, David
    Kool, Marcel
    Milde, Till
    Berger, Walter
    Pfister, Stefan M.
    Schueler, Julia
    CANCER RESEARCH, 2022, 82 (12)
12345